NASDAQ Biotechnology
NBI
3,840.99
-8.64
-0.22%
NASDAQ Biotechnology
The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
The Index began on November 1, 1993 at a base value of 200.00.
Last | 3,840.99 |
Net Change | -8.64 |
Net Change(%) | -0.22% |
Day High | 3,859.39 |
Day Low | 3,802.22 |
Previous Close | 3,840.99 |
Base Value | 200.00 |
Divisor | 1,117,018,053 |
Name | Symbol | Sponsor |
---|---|---|
ProShares Ultra NASDAQ Biotechnology ETF | BIB |
ProShares Trust
|
ProShares UltraShort NASDAQ Biotechnology ETF | BIS |
ProShares Trust
|
Invesco Nasdaq Biotechnology ETF | IBBQ |
Invesco
|
Invesco NASDAQ Biotech UCITS ETF | SBIO |
Invesco PowerShares
|
Tin'Koff Nasdaq Biotech | TBIO |
Tinkoff Capital
|
Capital NASDAQ Biotechnology Index Exchang Traded Fund | 678 |
Capital Securities Inv Tst Co.
|
Mirae Asset TIGER Nasdaq BIO ETF | 203780 |
Mirae Asset MAPS Global Investment Co., Ltd
|
Name | Symbol | Sponsor |
---|---|---|
KSM ETF (4A) NASDAQ Biotechnology Currency Hedged | KSMF168 |
KSM Mutual Funds Ltd
|
TachSAL(4A) Comp S&PHealth(70%)NAS BIO(30%) Currency Hedged | TCHF53 |
Meitav Tachlit Mutual Funds Ltd.
|
Nasdaq Biotechnology Index Mother Fund | 04312181- |
Daiwa Asset Management Co. Ltd.
|
Tachlit SAL (4A) NASDAQ Biotechnology Currency-Hedged | TCHF142 |
Meitav Tachlit Mutual Funds Ltd.
|
Tachlit SAL (4D) NASDAQ Biotechnology | TCHF80 |
Meitav Tachlit Mutual Funds Ltd.
|